Press Releases Organogenesis Holdings Inc.

Equities

ORGO

US68621F1021

Market Closed - Nasdaq Other stock markets 04:30:01 2024-05-03 pm EDT			5-day change	1st Jan Change
2.49 ^USD	0.00%		+8.97%	-39.12%

May. 02	Organogenesis Achieves Primary Endpoint in Phase 3 Clinical Trial of ReNu for Knee Osteoarthritis	CI
Feb. 29	Transcript : Organogenesis Holdings Inc., Q4 2023 Earnings Call, Feb 29, 2024

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Organogenesis Achieves Primary Endpoint in Phase 3 Clinical Trial of ReNu® for Knee Osteoarthritis	May. 02	AQ
Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2024 Financial Results on May 9, 2024	Apr. 16	AQ
Organogenesis Announces Favorable Court Ruling Dismissing Securities Fraud Case	Apr. 03	AQ
Organogenesis: Q4 Earnings Snapshot	Feb. 29	AQ
Organogenesis Holdings Inc. Reports Fourth Quarter 2023 and Fiscal Year 2023 Financial Results; Introduces Fiscal Year 2024 Guidance	Feb. 29	AQ
Organogenesis Holdings Inc. to Participate in the BTIG Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools Conference	Feb. 12	AQ
Organogenesis Holdings Inc. to Report Fourth Quarter and Fiscal Year 2023 Financial Results on February 29, 2024	Feb. 08	AQ
HippoFi Hires World's Top Regenerative Therapy Expert, Dr. Gail Naughton, to Drive Commercialization Plans of its Proprietary Technologies	Dec. 12	AQ
ORGANOGENESIS ALERT: Bragar Eagel & Squire, P.C. is Investigating Organogenesis Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm	Dec. 06	BU
Organogenesis: Q3 Earnings Snapshot	Nov. 09	AQ
Organogenesis Holdings Inc. Reports Third Quarter 2023 Financial Results	Nov. 09	AQ
Organogenesis Holdings Inc. to Report Third Quarter of Fiscal Year 2023 Financial Results on November 9, 2023	23-10-05	AQ
Organogenesis Applauds Withdrawal of Local Coverage Determinations by Novitas, First Coast Service Options and CGS	23-09-28	AQ
Organogenesis Holdings Inc. to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference	23-09-06	AQ
Organogenesis: Q2 Earnings Snapshot	23-08-09	AQ
Organogenesis Holdings Inc. Reports Second Quarter 2023 Financial Results; Withdraws Fiscal Year 2023 Guidance	23-08-09	AQ
Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2023 Financial Results on August 9, 2023	23-07-10	AQ
Organogenesis: Q1 Earnings Snapshot	23-05-10	AQ
ORGANOGENESIS HOLDINGS INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)	23-05-10	AQ
Organogenesis Holdings Inc. Reports First Quarter 2023 Financial Results	23-05-10	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Organogenesis Holdings Inc.

Equities

ORGO

US68621F1021

Press Releases

Filters